COVID-19–Associated Benzodiazepine-Resistant Catatonia Responds to Amantadine

Maju Mathew Koola, MD; Joan Oh, BA; Katrina Amber-Monta, MD; Syed Ammar, MD; Puneet Chawla Sahota, MD, PhD; Basant K. Pradhan, MD

Prim Care Companion CNS Disord 2022;24(6):22cr03394

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (12)

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. WHO website. Accessed October 20, 2022. https://covid19.who.int/
Scheiner NS, Smith AK, Wohlleber M, et al. COVID-19 and catatonia: a case series and systematic review of existing literature. J Acad Consult Liaison Psychiatry. 2021;62(6):645–656. PubMed CrossRef
Bush G, Fink M, Petrides G, et al. Catatonia, I: rating scale and standardized examination. Acta Psychiatr Scand. 1996;93(2):129–136. PubMed CrossRef
Dawood AS, Dawood A, Dawood S. Catatonia after COVID-19 infection: scoping review. BJPsych Bull. 2022:1–12. PubMed CrossRef
Sienaert P, Dhossche DM, Vancampfort D, et al. A clinical review of the treatment of catatonia. Front Psychiatry. 2014;5:181. PubMed CrossRef
Raffin M, Zugaj-Bensaou L, Bodeau N, et al. Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry. 2015;24(4):441–449. PubMed CrossRef
Miles JH, Takahashi N, Muckerman J, et al. Catatonia in Down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients. Neuropsychiatr Dis Treat. 2019;15:2723–2741. PubMed CrossRef
Ahuja N, Carroll BT. Possible anti-catatonic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(4):968–969. PubMed CrossRef
Sorg EM, Chaney-Catchpole M, Hazen EP. Pediatric catatonia: a case series-based review of presentation, evaluation, and management. Psychosomatics. 2018;59(6):531–538. PubMed CrossRef
Carroll BT, Goforth HW, Thomas C, et al. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci. 2007;19(4):406–412. PubMed CrossRef
Hosenbocus S, Chahal R. Amantadine: a review of use in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry. 2013;22(1):55–60. PubMed
Fink K, Nitsche A, Neumann M, et al. Amantadine inhibits SARS-CoV-2 in vitro. Viruses. 2021;13(4):539. PubMed CrossRef